Preimplantation genetic testing for aneuploidy in various protocols of assisted reproductive technologies with vitrified embryo

1. Barbosa M.W.P., Valadares N.P.B., Barbosa A.C.P., Amaral A.S., Iglesias J.R., Nastri C.O. et al. Oral dydrogesterone vs. vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer: a systematic review and meta-analysis. JBRA Assist. Reprod. 2018; 22(2): 148-56. https://
2. dx.doi.org/10.5935/1518-0557.20180018.
3. Tomic V., Kasum M., Vucic K. The role of luteal support during IVF: a qualitative systematic review. Gynecol. Endocrinol. 2019; 35(10): 829-34. https://dx.doi.org/10.1080/09513590.2019.1603288.
4. Atzmon Y., Aslih N., Estrada D., Bilgory A., Ellenbogen A., Shalom-Paz E. Comparable outcomes using oral dydrogesterone vs. micronized vaginal progesterone in frozen embryo transfer: a retrospective cohort study. Reprod. Sci. 2020 Nov 2. https://dx.doi.org/10.1007/s43032-020-00376-3.
5. Thakre N., Homburg R. A review of IVF in PCOS patients at risk of ovarian hyperstimulation syndrome. Expert Rev. Endocrinol. Metab. 2019; 14(5): 315-9. https://dx.doi.org/10.1080/17446651.2019.1631797.
6. Женское бесплодие (современные подходы к диагностике и лечению) клинические рекомендации (протокол лечения). Письмо Минздрава Российской Федерации от 15 февраля 2019 г. № 15-4/И/2-1218. [Female infertility (modern approaches to diagnosis and treatment) clinical recommendations (treatment protocol). Letter No. 15-4/I/2-1218 of the Ministry of Health of the Russian Federation dated February 15, 2019. (in Russian)]. Available at: http://www.consultant.ru/document/cons_doc_LAW_319098/ESHRE Reproductive Endocrinology Guideline Group Ovarian Stimulation for IVF/ICSI. Available at: https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Ovarian-Stimulation-in-IVF-ICSI Accessed 3 April 2020.
7. Квашнина Е.В., Тутаков М.А., Томина Е.В., Берестецкая О.С., Немсцверидзе Э.Я., Шилова Н.В. Сегментация цикла вспомогательных репродуктивных технологий как инструмент повышения эффективности преодоления бесплодия. Уральский медицинский журнал. 2019; 5: 116-23. [Kvashnina E.V., Tutakov M.A., Tomina E.V. et al. Segmentation of the cycle of assisted reproductive technologies as a tool to improve the efficiency of overcoming infertility. Uralskiy meditsinskiy zhurnal/ Ural medical journal. 2019; 5: 116-23. (in Russian)].
8. Harris M., Taylor G. Medical statistics made easy. London: Taylor and Francis; 2006. 114р.
9. Vercellini P., Consonni D., Dridi D., Bracco B., Frattaruolo M.P., Somigliana E. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum. Reprod. 2014; 29(5): 964-77. https://dx.doi.org/10.1093/humrep/deu041.
10. Бейк Е.П., Сыркашева А.Г., Долгушина Н.В. Эффективность программ вспомогательных репродуктивных технологий у пациенток позднего репродуктивного возраста. Гинекология. 2018; 20(1): 109-12. [Beik E.P., Syrkasheva A.G., Dolgushina N.V. Effectiveness of assisted reproductive technology programs in patients of late reproductive age. Gynecology. 2018; 20(1): 109-12. (in Russian)]. URL: https://cyberleninka.ru/article/n/effektivnost-programm-vspomogatelnyh-reproduktivnyh-tehnologiy-u-patsientok-pozdnego-reproduktivnogo-vozrasta.
11. Bergh C., Josefsson B., Nilsson L., Hamberger L. The success rate in a Swedish in-vitro fertilization unit: a cohort study. Acta Obstet. Gynecol. Scand. 1995; 74(6): 446-50.
12. Coates A., Kung A., Mounts E., Hesla J., Bankowski B., Barbieri E. et al. Optimal euploid embryo transfer strategy, fresh versus frozen, after preimplantation genetic screening with next generation sequencing: a randomized controlled trial. Fertil. Steril. 2017; 107(3): 723-30. e3. https://dx.doi.org/10.1016/j.fertnstert.2016.12.022.
13. Griesinger G., Blockeel C., Tournaye H. Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard? Fertil. Steril. 2018; 109(5): 756-62. https://dx.doi.org/10.1016/j.fertnstert.2018.03.034.
14. Schmutzler A.G. Theory and practice of preimplantation genetic screening (PGS). Eur. J. Med. Genet. 2019; 62(8): 103670. https://dx.doi.org/10.1016/j.ejmg.2019.103670.
15. Рыбина А.Н., Хорошилова И.Г., Исенова С.Ш., Локшин В.Н. Современные методы повышения эффективности вспомогательных репродуктивных технологий в Казахстане. Вестник Казахского национального медицинского университета. 2019; 1: 23-6. [Rybina A. N., Khoroshilova I. G., Isenova S. Sh., Lokshin V. N. Modern methods of improving the effectiveness of assisted reproductive technologies in Kazakhstan. Bulletin of KazNMU. 2019; 1: 23-6. (in Russian)]. Available at: https://cyberleninka.ru/article/n/sovremennye-metody-povysheniya-effektivnosti-vspomogatelnyh-reproduktivnyh-tehnologiy-v-kazahstane.
16. Geraedts J., Sermon K. Preimplantation genetic screening 2.0: the theory. Mol. Hum. Reprod. 2016; 22(8): 839-44. https://dx.doi.org/10.1093/molehr/gaw033.
17. Fedorova E.M., Shlykova S.A., Shunkina K.V., Zaitceva O.G., Lapina E.N., Yanchuk T.V., Kalugina A.S. Outcomes of IVF cycles coupled with PGS by aCGH of embryos from donor and autologous oocytes, transferred after vitrification to women of advanced maternal age. Gynecol. Endocrinol. 2017; 33(9): 737-40. https://dx.doi.org/10.1080/09513590.2017.1318274.
18. Coates A., Bankowski B.J., Kung A., Griffin D.K., Munne S. Differences in pregnancy outcomes in donor egg frozen embryo transfer (FET) cycles following preimplantation genetic screening (PGS): a single center retrospective study. J. Assist. Reprod. Genet. 2017; 34(1): 71-8. https://dx.doi.org/10.1007/s10815-016-0832-z.

Received 07.03.2021

Accepted 11.03.2021